Draft Of Bacteriophage Therapy Review
DOI:
https://doi.org/10.54097/hfwfxj54Keywords:
Phage therapy; Brief history of phage therapy; Application of phage therapy in plants; Current state of phage therapy; Development Prospects of phage therapy.Abstract
Phage therapy, which uses bacterial viruses (bacteriophages) to treat bacterial infections. In recent years, the issue of antibiotic resistance in various bacteria has become prominent, and the effectiveness of antibiotic drugs has generally declined, which has re raised people's scrutiny of bacteriophage therapy. Traditionally, bacteriophage therapy relies on the use of natural bacteriophages to infect and dissolve bacteria at the site of infection. Current research on the use of bacteriophages and their lytic proteins to combat multidrug-resistant bacterial infections suggests that bacteriophage therapy may serve as a substitute or supplement to antibiotic therapy.
Downloads
References
Mendelson M, Matsoso MP. The World Health Organization Global Action Plan for antimicrobial resistance[J]. S Afr Med J, 2015, 105(5):325.
Sulakvelidze, A., Alavidze, Z., & Morris Jr, J. G. (2001). Bacteriophage therapy. Antimicrobial agents and chemotherapy, 45(3), 649-659.
Wright A, Hawkins CH, Anggård EE, et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy[J]. Clin Otolaryngol, 2009, 34(4):349-357.
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., & Kuhl, S. (2010). Phage therapy in clinical practice: treatment of human infections. Current pharmaceutical biotechnology, 11(1), 69-86.
Chanishvili N. Phage therapy--history from Twort and d’Herelle through Soviet experience to current approaches. Adv Virus Res 2012; 83: 3-40 [PMID: 22748807 DOI: 10.1016/B978-0-12-394438-2.00001-3]
Sulakvelidze A, Alavidze Z, Morris JG. Bacteriophage therapy. Antimicrob Agents Chemother 2001; 45: 649-659 [PMID: 11181338 DOI: 10.1128/AAC.45.3.649-659.2001]
Hodyra-Stefaniak K, Miernikiewicz P, Drapała J, Drab M, Jończyk-Matysiak E, Lecion D, Kaźmierczak Z, Beta W, Majewska J, Harhala M, Bubak B, Kłopot A, Górski A, Dąbrowska K. Mammalian Host-Versus-Phage immune response determines phage fate in vivo. Sci Rep 2015; 5: 14802 [PMID: 26440922 DOI: 10.1038/srep14802]
Carlton RM. Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) 1999; 47: 267-274 [PMID: 10604231]
Weber-Dabrowska B, Mulczyk M, Górski A. Bacteriophage therapy of bacterial infections: an update of our institute’s experience. Arch Immunol Ther Exp (Warsz) 2000; 48: 547-551 [PMID: 11197610]
Delbrück M. The growth of bacteriophage and lysis of the host. J Gen Physiol 1940; 23: 643-660 [PMID: 19873180]
Weinbauer MG. Ecology of prokaryotic viruses. FEMS Microbiol Rev 2004; 28: 127-181 [PMID: 15109783 DOI: 10.1016/j.femsre. 2003.08.001]
Suttle, C. A. (2005). Viruses in the sea. Nature, 437(7057), 356-361. doi: 10.1038/nature04160
Catalão, M. J., Gil, F., Moniz-Pereira, J., & Pimentel, M. (2013). Diversity in bacterial lysis systems: bacteriophages show the way. FEMS Microbiology Reviews, 37(3), 554-571. doi: 10.1111/1574-6976.12018
Rakhuba DV, Kolomiets EI, Dey ES, Novik GI. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Pol J Microbiol 2010; 59: 145-155 [PMID: 21033576]
Labrie, S. J., Samson, J. E., & Moineau, S. (2010). Bacteriophage resistance mechanisms. Nature Reviews Microbiology, 8(4), 317-327.
Abedon, S. T. (2017). Bacteriophage resistance mechanisms: new approaches to combat antimicrobial resistance. Journal of Basic Microbiology, 57(8), 640-656.
Wang, X., Kim, Y., Ma, Q., Hong, S. H., Pokusaeva, K., Sturino, J. M., ... & Wood, T. K. (2010). Cryptic prophages help bacteria cope with adverse environments. Nature Communications, 1(1), 1-8.
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., ... & Horvath, P. (2007). CRISPR provides acquired resistance against viruses in prokaryotes. Science, 315(5819), 1709-1712.
Koskella B, Brockhurst MA. Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol Rev 2014; 38: 916-931 [PMID: 24617569 DOI: 10.1111/1574-6976.12072
Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol 2010; 8: 317-327 [PMID: 20348932 DOI: 10.1038/nrmicro2315]
Koskella, B., & Brockhurst, M. A. (2014). Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS microbiology reviews, 38(5), 916-931.
Chaturongakul, S., & Ounjai, P. (2014). Phage–host interplay: examples from tailed phages and Gram-negative bacterial pathogens. Frontiers in microbiology, 5, 442.
Samson, J. E., & Moineau, S. (2013). Bacteriophages in food fermentations: new frontiers in a continuous arms race. Annual review of food science and technology, 4, 347-368.
Sulakvelidze A, Alavidze Z, Morris Jr JG. Bacteriophage therapy. Antimicrobial agents and chemotherapy. 2001 Apr;45(3):649-59.
Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future microbiology. 2013 Feb;8(6):769-83.
Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST. Phage therapy in clinical practice: treatment of human infections. Current Pharmaceutical Biotechnology. 2010 Jan 1;11(1):69-86.
Oechslin F, Piccardi P, Mancini S, Gabard J, Moreillon P, Entenza JM, Resch G. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. The Journal of Infectious Diseases. 2017 May 15;215(10):703-12.
Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrobial agents and chemotherapy. 2017 Sep 22;61(10):e00954-17
Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol 2013; 8: 769-783 [PMID: 23701332 DOI: 10.2217/fmb.13.47]
Mai V, Ukhanova M, Reinhard MK, Li M, Sulakvelidze A. Bacteriophage administration significantly reduces Shigella colonization and shedding by Shigella-challenged mice without deleterious side effects and distortions in the gut microbiota. Bacteriophage 2015; 5: e1088124 [PMID: 26909243 DOI: 10.1080/21597081.2015.1088124]
Galtier M, De Sordi L, Maura D, Arachchi H, Volant S, Dillies MA, Debarbieux L. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition. Environ Microbiol 2016; 18: 2237-2245 [PMID: 26971586 DOI: 10.1111/1462-2920.13284]
Watanabe R, Matsumoto T, Sano G, Ishii Y, Tateda K, Sumiyama Y, Uchiyama J, Sakurai S, Matsuzaki S, Imai S, Yamaguchi K. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother 2007; 51: 446-452 [PMID: 17116686 DOI: 10.1128/AAC.00635-06]
Soothill JS. Treatment of experimental infections of mice with bacteriophages. J Med Microbiol 1992; 37: 258-261 [PMID: 1404324 DOI: 10.1099/00222615-37-4-258]
Pouillot F, Chomton M, Blois H, Courroux C, Noelig J, Bidet P, Bingen E, Bonacorsi S. Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b: H4-ST131 Escherichia coli strain producing CTX-M-15. Antimicrob Agents Chemother 2012; 56: 3568-3575 [PMID: 22491690 DOI: 10.1128/AAC.06330-11]
Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, Turner PE. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci Rep 2016; 6: 26717 [PMID: 27225966 DOI: 10.1038/srep26717]
Monk AB, Rees CD, Barrow P, Hagens S, Harper DR. Bacteriophage applications: where are we now? Lett Appl Microbiol 2010; 51: 363-369 [PMID: 20796209 DOI: 10.1111/j.1472-765X.2010.02916.x]
Nannapaneni R, Soni KA. Use of Bacteriophages to Remove Biofilms of Listeria monocytogenes and other Foodborne Bacterial Pathogens in the Food Environment. Biofilms in the Food Environment, Second Edition. USA: John Wiley & Sons, Ltd., 2015: 131-144 [DOI: 10.1002/ 9781118864036.ch5]
Endersen L, O’Mahony J, Hill C, Ross RP, McAuliffe O, Coffey A. Phage therapy in the food industry. Annu Rev Food Sci Technol 2014; 5: 327-349 [PMID: 24422588 DOI: 10.1146/annurev-food-030713-092415]
Schofield DA, Sharp NJ, Vandamm J, Molineux IJ, Spreng KA, Rajanna C, Westwater C, Stewart GC. Bacillus anthracis diagnostic detection and rapid antibiotic susceptibility determination using ‘bioluminescent’ reporter phage. J Microbiol Methods 2013; 95: 156-161 [PMID: 23994352 DOI: 10.1016/j.mimet.2013.08.013]
Bruttin A, Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 2005; 49: 2874-2878 [PMID: 15980363 DOI: 10.1128/AAC.49.7.2874-2878.2005]
Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, Lavigne R, Volckaert G, Mattheus W, Verween G, De Corte P, Rose T, Jennes S, Zizi M, De Vos D, Vaneechoutte M. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 2009; 4: e4944 [PMID: 19300511 DOI: 10.1371/journal.pone.0004944]
McCallin S, Alam Sarker S, Barretto C, Sultana S, Berger B, Huq S, Krause L, Bibiloni R, Schmitt B, Reuteler G, Brüssow H. Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. Virology 2013; 443: 187-196 [PMID: 23755967 DOI: 10.1016/j.virol.2013.05.022]
Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, Akter M, Huq S, Qadri F, Talukdar K, Kassam M, Delley M, Loiseau C, Deng Y, El Aidy S, Berger B, Brüssow H. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine 2016; 4: 124-137 [PMID: 26981577 DOI: 10.1016/j.ebiom.2015.12.023]
Wright A, Hawkins CH, Anggård EE, Harper DR. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 2009; 34: 349-357 [PMID: 19673983 DOI: 10.1111/j.1749-4486.2009.01973.x]
Abedon, S.T. (2017). Phage Therapy: Past, Present and Future. Springer International Publishing.
Chhibber, S., & Kaur, S. (2019). Challenges and future prospects for the delivery of bacteriophages in vivo. Journal of Medical Microbiology, 68(1), 1-6.
Jessica S. Little 1,2,3,8✉, Rebekah M. Dedric, Bacteriophage treatment of disseminated,2022 cutaneous Mycobacterium chelonae infection.
Witzenrath M, Schmeck B, Doehn JM, Tschernig T, Zahlten J, Loeffler JM, Zemlin M, Müller H, Gutbier B, Schütte H, Hippenstiel S, Fischetti VA, Suttorp N, Rosseau S. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Crit Care Med 2009; 37: 642-649 [PMID: 19114881 DOI: 10.1097/CCM.0b013e31819586a6
Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853-860.
Mohamed et al,Bacteriophage cocktail significantly reduces Escherichia coli O18:K1:H7 recovery from lung in a mouse pneumonia model,Frontiers in Microbiology,2018
Kering K.K., Kibii B.J., Wei H. Biocontrol of phytobacteria with bacteriophage cocktails. Pest Manag. Sci. 2019;75:1775–1781. doi: 10.1002/ps.5324.
Gu J., Liu X., Li Y., Han W., Lei L., Yang Y., Zhao H., Gao Y., Song J., Lu R. A method for generation phage cocktail with great therapeutic potential. PLoS ONE. 2012;7:e31698. doi: 10.1371/journal.pone.0031698.
Sabri M., Benkirane R., Habbadi K., Sadik S., Ou-Zine M., Diouri M., Achbani E.H. Phages as a potential biocontrol of phytobacteria. Arch. Phytopathol. Plant Prot. 2021;54:1277–1291. doi: 10.1080/03235408.2021.1902033.
Álvarez B., López M.M., Biosca E.G. Biocontrol of the major plant pathogen Ralstonia solanacearum in irrigation water and host plants by novel waterborne lytic bacteriophages. Front. Microbiol. 2019;10:2813. doi: 10.3389/fmicb.2019.02813.
Zaczek-Moczydłowska M.A., Young G.K., Trudgett J., Fleming C.C., Campbell K., O’Hanlon R. Genomic characterization, formulation and efficacy in planta of a siphoviridae and podoviridae protection cocktail against the bacterial plant pathogens Pectobacterium spp. Viruses. 2020;12:150. doi: 10.3390/v12020150
Das M., Bhowmick T.S., Ahern S.J., Young R., Gonzalez C.F. Control of Pierce’s disease by phage. PLoS ONE. 2015;10:e0128902. doi: 10.1371/journal.pone.0128902.
Koskella B., Taylor T.B. Multifaceted impacts of bacteriophages in the plant microbiome. Annu. Rev. Phytopathol. 2018;56:361–380. doi: 10.1146/annurev-phyto-080417-045858.
Iriarte F. B., Obradović A., Wernsing M. H., Jackson L. E., Balogh B., Hong J. A., et al. (2012). Soil-based systemic delivery and phyllosphere in vivo propagation of bacteriophages: two possible strategies for improving bacteriophage persistence for plant disease control. Bacteriophage 2 215–224. 10.4161/bact.23530
Hirst J. M., Riche H. H., Bascomb C. L. (1961). Copper accumulation in the soils of apple orchards near Wisbech. Plant Pathol. 10 105–108. 10.1111/j.1365-3059.1961.tb00127.x
Hirst J. M., Riche H. H., Bascomb C. L. (1961). Copper accumulation in the soils of apple orchards near Wisbech. Plant Pathol. 10 105–108. 10.1111/j.1365-3059.1961.tb00127.x
Rakhuba, D. V.; Kolomiets, E. I.; Dey, E. S.; Novik, G. I. Bacteriophage Receptors, Mechanisms of Phage Adsorption and Penetration into Host Cell. Polish J. Microbiol. / Pol. Tow. Mikrobiol. = Polish Soc. Microbiol.2010, 59(3), 145–155
Osserman, E. F.; Canfield, R. E.; Beychok, S. Lysozyme; Osserman, E., Ed.; Academic Press Inc., 1974
Salmond G.P., Fineran P.C. A century of the phage: Past, present and future. Nat. Rev. Microbiol. 2015;13:777–786. doi: 10.1038/nrmicro3564.
Mäntynen S., Laanto E., Oksanen H.M. Black box of phage–bacterium interactions: Exploring alternative phage infection strategies. Open Biol. 2021;11:210188. doi: 10.1098/rsob.210188.
Wolfram-Schauerte M, Pozhydaieva N, Viering M, Glatter T, Höfer K. Integrated Omics Reveal Time-Resolved Insights into T4 Phage Infection of E. coli on Proteome and Transcriptome Levels. Viruses. 2022 Nov 12;14(11):2502. doi: 10.3390/v14112502. PMID: 36423111; PMCID: PMC9697503.
Farooq T, Hussain MD, Shakeel MT, Tariqjaveed M, Aslam MN, Naqvi SAH, Amjad R, Tang Y, She X, Her Z. Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens. Viruses. 2022 Jan 18;14(2):171. doi: 10.3390/v14020171. PMID: 35215763; PMCID: PMC8879233.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
